Animation - Understanding Immunotherapy for Lung Cancer

Slide Show - Understanding Immunotherapy for Lung Cancer

Animation - Immunotherapy Treatments for NSCLC

Slide Show - Immunotherapy Treatments for NSCLC

Animation - Immunotherapy Treatments for SCLC

Slide Show - Immunotherapy Treatments for SCLC

Animation - Immunotherapy Treatments for Non-small Cell Lung Cancer (NSCLC)

This animation provides an overview of several immunotherapy treatments that have been approved for non-small cell lung cancer (NSCLC). Immunotherapy is the use of medicines to stimulate the body's immune system to recognize and attack cancer cells. This animation also describes how your doctor will evaluate whether immunotherapy is right for you, possible treatment side effects, and clinical trials. It's important to discuss all treatment options with your doctor or cancer care team, so you can make the best decisions that are right for you. Side effects of immunotherapy are often treated with prednisone, a drug that suppresses your immune system. Your immunotherapy will be stopped until the side effects clear up.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Section: Immunotherapy for Lung Cancer

Animation - Understanding Immunotherapy for Lung Cancer

Slide Show - Understanding Immunotherapy for Lung Cancer

Animation - Immunotherapy Treatments for NSCLC

Slide Show - Immunotherapy Treatments for NSCLC

Animation - Immunotherapy Treatments for SCLC

Slide Show - Immunotherapy Treatments for SCLC

Other Modules:

Treatment and Management of Lung Cancer

Targeted Therapy in Non-Small Cell Lung Cancer

Understanding Non-Small Cell Lung Cancer (NSCLC)

Understanding Small Cell Lung Cancer (SCLC)

Screening for Lung Cancer

Lung Cancer Screening for Black Americans

Lung Cancer Screening for Native Americans

Diagnosis and Screening of Lung Cancer

Staging of Lung Cancer

Understanding Biomarker Testing in Non-Small Cell Lung Cancer

Understanding Clinical Trials in Lung Cancer

Lung Cancer Clinical Trials and the US Black Community

Lung Cancer Clinical Trials and Native Americans

NSCLC Treatment When You Have an EGFR Mutation

NSCLC Treatment Options When You Have an EGFR Mutation

NSCLC Treatment When You Have a KRAS Mutation

NSCLC Treatment Options When You Have a KRAS Mutation

NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET

Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Understanding Prehabilitation for Lung Cancer Surgery

Your Prehabilitation Plan for Lung Cancer Surgery

Patient Stories:

Mr. Satterfield's Story

Sharon’s Story

Terri's Story

Tricia's Story

This educational activity has been developed by A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed shared decisions, and partner with their healthcare professionals for optimal outcomes.